4//SEC Filing
Ford Robert B 4
Accession 0001415889-25-003394
CIK 0000001800other
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 5:51 PM ET
Size
9.9 KB
Accession
0001415889-25-003394
Insider Transaction Report
Form 4
Ford Robert B
Senior Vice President
Transactions
- Exercise/Conversion
Common shares without par value
2025-02-05$38.40/sh+285,388$10,958,899→ 505,447 total - Sale
Common shares without par value
2025-02-05$131.17/sh−285,388$37,435,200→ 220,059 total - Exercise/Conversion
Option (right to buy)
2025-02-05−285,388→ 0 totalExercise: $38.40From: 2019-02-19Exp: 2026-02-18→ Common Shares (285,388 underlying)
Holdings
- 197,403(indirect: By Trust)
Common shares without par value
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.68 to $131.38, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F2]Held in the Ford Family Trust DTD June 2, 2014. The reporting person is co-trustee of the trust.
- [F3]Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
Documents
Issuer
ABBOTT LABORATORIES
CIK 0000001800
Entity typeother
Related Parties
1- filerCIK 0001612571
Filing Metadata
- Form type
- 4
- Filed
- Feb 6, 7:00 PM ET
- Accepted
- Feb 7, 5:51 PM ET
- Size
- 9.9 KB